Sectors
ATOS
Atossa Therapeutics, Inc.
2.37
21 x 2.36
1 x 2.42
bid
ask
+
0.01
0.42%
undefined @ 04:00 PM
2.42 +0.05 (2.11%)
| Ytd | -73.22% | |
| 1y | -80.00% |
2.33
day range
2.44
1.70
52 week range
19.35
| Open | 2.33 | Prev Close | 2.36 | Low | 2.33 | High | 2.44 | Mkt Cap | 23.64M |
| Vol | 67.01K | Avg Vol | 152.10K | EPS | -3.42 | P/E | -0.69 | Forward P/E | -3.81 |
| Beta | 1.23 | Short Ratio | 14.73 | Inst. Own | 28.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.75 | 200-d Avg | 6.63 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 9.87M | ||
| Research and Development Expense | 4.78M | ||
| Selling, General and Administrative Expense | 5.09M | ||
| Operating Income | -9.87M | ||
| Net Income | -9.59M | ||
| Net Income Common Stock | -9.59M | ||
| Net Income Common Stock (USD) | -9.59M | ||
| Consolidated Income | -9.59M | ||
| Earnings per Basic Share | -1.11 | ||
| Earnings per Basic Share (USD) | -1.11 | ||
| Earnings per Diluted Share | -1.11 | ||
| Earning Before Interest & Taxes (EBIT) | -9.59M | ||
| Earning Before Interest & Taxes (USD) | -9.59M | ||
| Weighted Average Shares | 8.62M | ||
| Weighted Average Shares Diluted | 8.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 31.83M | ||
| Cash and Equivalents (USD) | 31.83M | ||
| Current Assets | 36.67M | ||
| Total Assets | 37.94M | ||
| Current Liabilities | 7.46M | ||
| Total Liabilities | 7.46M | ||
| Accumulated Retained Earnings (Deficit) | -256.15M | ||
| Shareholders Equity | 30.49M | ||
| Shareholders Equity (USD) | 30.49M | ||
| Assets Non-Current | 1.27M | ||
| Trade and Non-Trade Payables | 2.57M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.58M | ||
| Net Cash Flow from Operations | -9.58M | ||
| Share Based Compensation | 722.00K | ||